Iomai Corporation is scoping out new antigen possibilities after
its patch-based vaccine for seasonal influenza failed to match the
immune response of the same vaccine administered by injection in a
Phase I clinical trial.
US company Sontra Medical has successfully completed the first
tests of a novel technology that allows vaccines to be applied
topically to the skin, rather than delivered through a needle.
Preliminary data suggest the method is as...
Genetically altered bacterial viruses appear to be more effective
than naked DNA in eliciting an immune response and could be a new
strategy for a next generation of vaccines that are easy to produce
and store, say researchers this...